1 U.S. lawmaker has disclosed 1 Quantinuum Inc. - trade under the STOCK Act — 1 buy and 0 sells in 2026. Congress has been net buyers of QNT, and their disclosed buys are up 13.4% versus the latest close.
*Notional-weighted price return on lawmakers' disclosed buys of QNT, marked to the latest close — per-share (share counts aren't disclosed).
1 member disclosed a QNT purchase in the last 90 days (newest first).
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2026-06-04 | Cleo Fields | BUY | $1K–$15K | $60.38 | $68.50 2026-08-13 | +13.4% |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
1 member of the U.S. House and Senate has disclosed Quantinuum Inc. - transactions under the STOCK Act — 1 purchase and 0 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
1 member disclosed a QNT purchase in the last 90 days — most recently Cleo Fields on 2026-06-04. See the "Lawmakers who bought QNT recently" section above for the dated list.
Notional-weighted, lawmakers' disclosed QNT buys are up 13.4% versus the latest close of $68.50. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded QNT and how it performed.